Literature DB >> 16906446

Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies.

Octavio Guerrero-Andrade1, Elizabeth Loza-Rubio, Teresa Olivera-Flores, Tamás Fehérvári-Bone, Miguel Angel Gómez-Lim.   

Abstract

Transgenic plants have been employed successfully as a low-cost system for the production of therapeutically valuable proteins, including antibodies, antigens and hormones. Here, we report the expression of the fusion (F) gene of the Newcastle disease virus (NDV) in transgenic maize plants. The expression of the transgene, driven by the maize ubiquitin promoter, caused accumulation of the F protein in maize kernels. The presence of the transgene was verified by Southern and western blots. Feeding chickens with kernels containing the F protein induced the production of antibodies, which conferred protection against a viral challenge. This protection was comparable to that conferred by a commercial vaccine. Possible uses of this plant-based F protein as a potential mucosal vaccine are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906446     DOI: 10.1007/s11248-006-0017-0

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   3.145


  35 in total

1.  Single-copy primary transformants of maize obtained through the co-introduction of a recombinase-expressing construct.

Authors:  V Srivastava; D W Ow
Journal:  Plant Mol Biol       Date:  2001-07       Impact factor: 4.076

Review 2.  Plant-based production of biopharmaceuticals.

Authors:  Rainer Fischer; Eva Stoger; Stefan Schillberg; Paul Christou; Richard M Twyman
Journal:  Curr Opin Plant Biol       Date:  2004-04       Impact factor: 7.834

3.  Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes.

Authors:  C F Loke; A R Omar; A R Raha; K Yusoff
Journal:  Vet Immunol Immunopathol       Date:  2005-07-15       Impact factor: 2.046

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.

Authors:  D J King
Journal:  Avian Dis       Date:  1999 Oct-Dec       Impact factor: 1.577

Review 6.  The avian response to Newcastle disease virus.

Authors:  B S Seal; D J King; H S Sellers
Journal:  Dev Comp Immunol       Date:  2000 Mar-Apr       Impact factor: 3.636

7.  Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence.

Authors:  B P Peeters; O S de Leeuw; G Koch; A L Gielkens
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity.

Authors:  L McGinnes; T Sergel; J Reitter; T Morrison
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

Review 9.  Structure and function of a paramyxovirus fusion protein.

Authors:  Trudy G Morrison
Journal:  Biochim Biophys Acta       Date:  2003-07-11

10.  Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy.

Authors:  N Kamiya; M Niikura; M Ono; C Kai; Y Matsuura; T Mikami
Journal:  Virus Res       Date:  1994-06       Impact factor: 3.303

View more
  17 in total

1.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

2.  Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.

Authors:  Celine A Hayden; Maria E Fischer; Bryan L Andrews; Hayley C Chilton; Debra D Turner; John H Walker; Ian R Tizard; John A Howard
Journal:  Vaccine       Date:  2015-05-02       Impact factor: 3.641

3.  Root-preferential expression of Newcastle virus glycoproteins driven by NtREL1 promoter in tobacco hairy roots and evaluation of oral delivery in mice.

Authors:  Narges Arkian Boroujeni; Somayeh Behjat Khatouni; Mohammad Javad Motamedi; Shaghayegh Afraz; Mahyat Jafari; Ali-Hatef Salmanian
Journal:  Transgenic Res       Date:  2022-01-10       Impact factor: 2.788

4.  Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy.

Authors:  Doreen Manuela Floss; Michael Mockey; Galliano Zanello; Damien Brosson; Marie Diogon; Roger Frutos; Timothée Bruel; Valérie Rodrigues; Edwin Garzon; Claire Chevaleyre; Mustapha Berri; Henri Salmon; Udo Conrad; Laurence Dedieu
Journal:  J Biomed Biotechnol       Date:  2010-04-13

5.  Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice.

Authors:  Melina Laguía-Becher; Valentina Martín; Mauricio Kraemer; Mariana Corigliano; María L Yacono; Alejandra Goldman; Marina Clemente
Journal:  BMC Biotechnol       Date:  2010-07-15       Impact factor: 2.563

6.  Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit.

Authors:  Yasunobu Matsumoto; Seiko Suzuki; Tomoko Nozoye; Takashi Yamakawa; Yasuhiro Takashima; Takeshi Arakawa; Naotoshi Tsuji; Fumio Takaiwa; Yoshihiro Hayashi
Journal:  Transgenic Res       Date:  2008-09-02       Impact factor: 2.788

Review 7.  Plant-based vaccines for animals and humans: recent advances in technology and clinical trials.

Authors:  Natsumi Takeyama; Hiroshi Kiyono; Yoshikazu Yuki
Journal:  Ther Adv Vaccines       Date:  2015-09

Review 8.  Corn-based vaccines: current status and prospects.

Authors:  Sergio Rosales-Mendoza; Cristhian Sández-Robledo; Bernardo Bañuelos-Hernández; Carlos Angulo
Journal:  Planta       Date:  2017-03-27       Impact factor: 4.116

Review 9.  Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals.

Authors:  Pit Sze Liew; Mohd Hair-Bejo
Journal:  Adv Virol       Date:  2015-08-13

Review 10.  The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.

Authors:  Young Hee Joung; Se Hee Park; Ki-Beom Moon; Jae-Heung Jeon; Hye-Sun Cho; Hyun-Soon Kim
Journal:  Int J Mol Sci       Date:  2016-10-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.